Penn Capital Management Co. Inc. lifted its stake in shares of ICU Medical, Inc. (NASDAQ:ICUI) by 9.4% in the 2nd quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 63,679 shares of the medical instruments supplier’s stock after buying an additional 5,470 shares during the period. Penn Capital Management Co. Inc. owned about 0.32% of ICU Medical worth $11,000,000 as of its most recent SEC filing.

Several other large investors also recently made changes to their positions in ICUI. Janney Montgomery Scott LLC increased its holdings in shares of ICU Medical by 0.4% during the first quarter. Janney Montgomery Scott LLC now owns 1,607 shares of the medical instruments supplier’s stock worth $245,000 after buying an additional 7 shares in the last quarter. Great West Life Assurance Co. Can increased its holdings in shares of ICU Medical by 6.5% during the first quarter. Great West Life Assurance Co. Can now owns 21,104 shares of the medical instruments supplier’s stock worth $3,222,000 after buying an additional 1,280 shares in the last quarter. State Board of Administration of Florida Retirement System increased its holdings in shares of ICU Medical by 1.9% during the first quarter. State Board of Administration of Florida Retirement System now owns 7,080 shares of the medical instruments supplier’s stock worth $1,081,000 after buying an additional 130 shares in the last quarter. First Trust Advisors LP increased its holdings in shares of ICU Medical by 42.0% during the first quarter. First Trust Advisors LP now owns 10,188 shares of the medical instruments supplier’s stock worth $1,556,000 after buying an additional 3,013 shares in the last quarter. Finally, Suntrust Banks Inc. increased its holdings in shares of ICU Medical by 3.0% during the first quarter. Suntrust Banks Inc. now owns 2,288 shares of the medical instruments supplier’s stock worth $347,000 after buying an additional 66 shares in the last quarter. Institutional investors own 78.13% of the company’s stock.

ICU Medical (NASDAQ:ICUI) last released its quarterly earnings data on Wednesday, August 9th. The medical instruments supplier reported $0.52 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.58 by ($0.06). ICU Medical had a net margin of 6.10% and a return on equity of 7.56%. The firm had revenue of $331.51 million during the quarter, compared to analysts’ expectations of $318.30 million. During the same quarter in the previous year, the firm posted $1.15 EPS. ICU Medical’s revenue was up 242.8% compared to the same quarter last year.

TRADEMARK VIOLATION WARNING: “ICU Medical, Inc. (ICUI) Shares Bought by Penn Capital Management Co. Inc.” was originally published by Daily Political and is the property of of Daily Political. If you are reading this news story on another site, it was stolen and republished in violation of US and international copyright & trademark laws. The correct version of this news story can be viewed at https://www.dailypolitical.com/2017/09/21/icu-medical-inc-icui-shares-bought-by-penn-capital-management-co-inc.html.

In other ICU Medical news, VP Virginia Ruth Sanzone sold 1,784 shares of the business’s stock in a transaction dated Thursday, September 7th. The shares were sold at an average price of $174.47, for a total value of $311,254.48. Following the transaction, the vice president now owns 102 shares in the company, valued at $17,795.94. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, Chairman Vivek Jain sold 100,000 shares of the business’s stock in a transaction dated Tuesday, July 11th. The shares were sold at an average price of $170.80, for a total transaction of $17,080,000.00. Following the completion of the transaction, the chairman now owns 110,925 shares in the company, valued at approximately $18,945,990. The disclosure for this sale can be found here. Insiders sold 213,012 shares of company stock worth $36,438,659 in the last 90 days. Corporate insiders own 15.90% of the company’s stock.

Several brokerages have recently issued reports on ICUI. BidaskClub downgraded shares of ICU Medical from a “buy” rating to a “hold” rating in a report on Tuesday, July 11th. Sidoti downgraded shares of ICU Medical from a “buy” rating to a “neutral” rating in a report on Tuesday, June 20th. Zacks Investment Research upgraded shares of ICU Medical from a “hold” rating to a “buy” rating and set a $193.00 price target for the company in a report on Thursday, July 20th. Finally, Gabelli reiterated a “buy” rating on shares of ICU Medical in a report on Friday, August 11th. One research analyst has rated the stock with a sell rating, three have issued a hold rating and one has issued a buy rating to the company. The stock has an average rating of “Hold” and an average target price of $193.00.

ICU Medical Profile

ICU Medical, Inc is engaged in the development, manufacture and sales of medical devices used in infusion therapy, oncology and critical care applications. The Company’s product line includes needlefree connection devices, custom infusion sets, closed system transfer devices (CSTD) for the handling of hazardous drugs, advanced sensor catheters, needlefree closed blood sampling systems, disposable pressure transducer systems and hemodynamic monitoring systems.

Want to see what other hedge funds are holding ICUI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for ICU Medical, Inc. (NASDAQ:ICUI).

Institutional Ownership by Quarter for ICU Medical (NASDAQ:ICUI)

Receive News & Ratings for ICU Medical Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ICU Medical Inc. and related companies with MarketBeat.com's FREE daily email newsletter.